Both Trump and Harris seek to lower drug costs for patients. What headway have they made on realizing this goal?
Author - Gabriel Parker
Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.
Athletes have different gut microbiomes compared with the general population. Some of these microbes are thought to improve endurance and recovery by optimizing the cell’s powerhouses.
Americans have long been divided over adopting permanent standard versus permanent daylight saving time. But support for permanent standard time grew dramatically between 2021 and 2024.
Cardio or weights first? A kinesiologist explains how to optimize the order of your exercise routine
How to structure your workout − resistance then aerobic training or vice versa − depends on your exercise goals.
An intriguing therapy that shifts what people perceive as the source of their pain could aid in pain management.
The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
Parsing the risk of myocarditis from viral infection versus vaccination is challenging, and researchers are intensely studying the various factors that are at play.
One way to prevent mental health challenges in children: Recognize and treat the mental health issues of their parents.
Overcoming the access barriers and biases that underrepresented and underserved communities face could not only improve research participation but also improve care.